Home
Search
Search Results
Previously Searched
3100 results found
Expand All
Apply All
3100 results found

BIO Applauds US Court of Appeals Decision on the Renewable Fuel Standard
Press Release  •  July 28, 2017
The U.S. Court of Appeals for the District of Columbia Circuit today supported BIO's argument that the RFS statute does not allow EPA to rely on demand-side factors under the oil industry’s control as a basis for setting annual renewable fuel volumes.
Read More

BIO Submits Comments on Program for Enhanced Review Transparency and Communication for Original 351(k) Biologics License Applications in Biosimilar User Fee Act II
Letters, Testimony & Comments  •  July 27, 2017
BIO submitted comments to the Food and Drug Administration (FDA) on the statement of work for assessment of the Program for Enhanced Review Transparency and Communication for Original 351(k) Biologics License Applications in Biosimilar User Fee Act II. BIO supports the approach described in the BsUFA II Performance Goals of establishing a review approach for biosimilars applications patterned generally after the program established under PDUFA V for New Molecular Entity (NME) and new Biological License Applications (BLAs). BIO agrees the evaluation must be public, include input from FDA staff and sponsors, and provide recommendations at the mid-point and at the end of the program for any changes necessary for the program to succeed.
Read More

The 2017 BIO World Congress Comes to a Close in Montreal
Agriculture & Environment, BIO One-on-One Partnering  •  Press Release  •  July 26, 2017
The 14th annual BIO World Congress drew 954 attendees. The world’s largest industrial biotechnology event hosted more than 227 speakers in seven education tracks and five plenaries and set a new conference record for partnering meetings.
Read More

Democrats' Plan on Drug Costs a “Bad Deal for Patients and the Future of American Innovation”
Press Release  •  July 24, 2017
Plan will restrict seniors’ access to prescription drugs and undermine quest for biopharmaceutical innovations and curesWashington, DC (July 24, 2017) – Biotechnology Innovation Organization (BIO) Director of Communications Brian Newell released the following statement regarding the drug cost plan released today by Congressional Democrats:
Read More

Gord Surgeoner to Receive 2017 BIO Leadership and Legacy Award
Press Release  •  July 18, 2017
Dr. Gord Surgeoner, OOnt, former president of Ontario Agri-Food Technologies (OAFT), will receive the 2nd annual BIO Leadership and Legacy Award on Wednesday July 26, 2017, during a lunch plenary session of the 2017 BIO World Congress on Industrial Biotechnology.
Read More

BIO Statement on the Status of the U.S.-China 100-Day Plan
Press Release  •  July 17, 2017
Washington, D.C. (July 17, 2017) – The Biotechnology Innovation Organization (BIO) today issued the following statement on the status of the U.S.-China 100-day plan:
Read More

Rhode Island Governor Gina Raimondo Presented 2017 BIO Governor of the Year Award
Press Release  •  July 14, 2017
BIO today presented Rhode Island Governor Gina Raimondo with its 2017 Governor of the Year award in recognition of her leadership and commitment to strengthening the bioscience industry within Rhode Island. Governor Raimondo received the award at the National Governor’s Association Summer Meeting, held at the Providence Convention Center.
Read More

BIO Files Amicus Brief Supporting Rehearing of Case Addressing Patent Rights and America Invents Act (AIA) at the U.S. Court of Appeals for the Federal Circuit
Amicus Brief  •  July 14, 2017
BIO files Amicus Brief supporting rehearing en banc in Helsinn v. Teva Phamaceuticals (US Court of Appeals for the Federal Circuit)
Read More

BIO Applauds House Passage of Food and Drug Administration Reauthorization Act (FDARA)
Press Release  •  July 12, 2017
Urges swift Senate vote to ensure continuity of critical FDA functions Washington, DC (July 12, 2017) – Biotechnology Innovation Organization (BIO) President and CEO James C. Greenwood issued the following statement today regarding passage of the Food and Drug Administration Reauthorization Act (FDARA) by the U.S. House of Representatives:
Read More

BIO Statement on EPA’s Proposed 2018 Renewable Fuel Standards
Press Release  •  July 5, 2017
Washington, D.C. (July 5, 2017) – The Environmental Protection Agency’s proposed Renewable Fuel Standards for 2018 and biomass-based diesel volume for 2019 must be improved to support investment and capacity building for advanced and cellulosic biofuels, the Biotechnology Innovation Organization (BIO) said today. 
Read More